Skip links

Firazyr® (icatibant)

Full Name Firazyr® (icatibant)
Drug Firazyr
Manufacturer Takeda Pharmaceuticals U.S.A., Inc.
Route of Administration Subcutaneous
Site of Care Home or Healthcare Facility
Approved Indication Treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older
Disease Hereditary Angioedema (HAE)
Therapeutic Area Allergy & Immunology
Enrollment Form Link Enrollment Form
Phone Number 800-356-4252
Fax Number 847-631-6918
Product Website firazyr.com/hcp